The comparison of eye side effects of Osferal and Deferoxamine in patients with major thalassemia
Not Applicable
- Conditions
- Major thalassemia.Beta thalassaemia
- Registration Number
- IRCT201110087677N1
- Lead Sponsor
- Vice chancellor for research Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
children having major thalassemia , being candidate for chelator therapy because of iron overload
Exclusion criteria: diabetes mellitus and rheumatologic diseases, any lens disease or chelator therapy before the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ens opacity. Timepoint: After one year. Method of measurement: Ophthalmologic examinations.
- Secondary Outcome Measures
Name Time Method Age- Gender- Family history. Timepoint: One year. Method of measurement: Answer sheet.